Fingerprint
Dive into the research topics where Anne Strik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring
Desai, D. C., Dherai, A. J., Strik, A. & Mould, D. R., Apr 2023, In: Journal of clinical pharmacology. 63, 4, p. 480-489 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile24 Downloads (Pure) -
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial
Strik, A. S., Löwenberg, M., Mould, D. R., Berends, S. E., Ponsioen, C. I., van den Brande, J. M. H., Jansen, J. M., Hoekman, D. R., Brandse, J. F., Duijvestein, M., Gecse, K. B., de Vries, A., Mathôt, R. A. & D’Haens, G. R., 2021, In: Scandinavian journal of gastroenterology. 56, 2, p. 145-154 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile53 Downloads (Pure) -
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples
Berends, S. E., Bloem, K., de Vries, A., Schaap, T., Rispens, T., Strik, A. S., Talwar, R., Löwenberg, M., DʼHaens, G. R. & Mathôt, R. A., 1 Apr 2020, In: Therapeutic drug monitoring. 42, 2, p. 289-294 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile29 Downloads (Pure) -
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
Berends, S. E., Strik, A. S., Löwenberg, M., D’Haens, G. R. & Mathôt, R. A. A., 2019, In: Clinical pharmacokinetics. 58, 1, p. 15-37Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Downloads (Pure) -
Hemolytic anemia after switching from infliximab originator to biosimilar CT-P13 in a patient with inflammatory bowel disease: A case report
Strik, A. S., D’Haens, G. R. & Löwenberg, M., 2019, In: Clinical case reports.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Downloads (Pure)